Design Principles and Applications of Ionic Liquids for Transdermal Drug Delivery
Source abstract
Abstract
Abstract Ionic liquids (ILs) are salts with melting points typically <100 °C, composed of specific anions and cations. Recently, IL application has expanded into material engineering and biomedicine. Due to their unique properties, ILs have garnered significant interest in pharmacological research as solubilizers, transdermal absorption enhancers, antibacterial agents, and stabilizers of insoluble pharmaceutical active ingredients. The improvement of skin permeability by ILs is closely associated with their specific physicochemical characteristics, which are identified by their ionic composition. However, the existing literature on transdermal medication administration is insufficient in terms of a comprehensive knowledge base. This review provides a comprehensive assessment of the design principles involved in IL synthesis. Additionally, it discusses the methods utilized to assess skin permeability and provides a focused outline of IL application in transdermal drug administration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ionic liquids properties and applications · Advancements in Transdermal Drug Delivery · Surfactants and Colloidal Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P. R. China
College of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P. R. China
Department of Pathology Peking University International Hospital Beijing 102206 P. R. China
Funding
National Key Research and Development Program of China
References (100+)
Show source-provided references
1. 10.1016/j.ejps.2021.10591510.1016/j.ejps.2021.105915 ↗
2. 10.3390/ijms22211199110.3390/ijms222111991 ↗
3. 10.1016/j.molliq.2021.11531010.1016/j.molliq.2021.115310 ↗
4. 10.1016/j.addr.2021.11399710.1016/j.addr.2021.113997 ↗
5. 10.3390/ijms2209433810.3390/ijms22094338 ↗
6. 10.1002/EXP.2021017010.1002/EXP.20210170 ↗
7. 10.1358/mf.2000.22.5.79664910.1358/mf.2000.22.5.796649 ↗
8. 10.1177/10499091960130060810.1177/104990919601300608 ↗
9. 10.1016/0002-9149(88)90090-210.1016/0002-9149(88)90090-2 ↗
10. 10.4103/aer.AER_68_1710.4103/aer.AER_68_17 ↗
11. Wong W. F. · Med. · 2023 · 59 · 778
12. 10.1016/j.addr.2014.01.00710.1016/j.addr.2014.01.007 ↗
13. 10.1166/jbn.2017.247410.1166/jbn.2017.2474 ↗
14. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
15. 10.1002/marc.20220003710.1002/marc.202200037 ↗
16. 10.1007/s13346-021-00898-610.1007/s13346-021-00898-6 ↗
17. 10.3389/fphar.2015.0021910.3389/fphar.2015.00219 ↗
18. 10.1186/s41702-020-0058-710.1186/s41702-020-0058-7 ↗
19. 10.1016/j.ijpharm.2013.02.04010.1016/j.ijpharm.2013.02.040 ↗
20. 10.1039/c2an35220f10.1039/c2an35220f ↗
21. 10.1016/S1461-5347(00)00295-910.1016/S1461-5347(00)00295-9 ↗
22. 10.1002/ejic.20170055310.1002/ejic.201700553 ↗
23. 10.1021/acs.chemrev.6b0059410.1021/acs.chemrev.6b00594 ↗
24. 10.1021/acs.chemrev.7b0024610.1021/acs.chemrev.7b00246 ↗
25. 10.1016/j.fluid.2004.02.00310.1016/j.fluid.2004.02.003 ↗
26. 10.1002/cmdc.20110008210.1002/cmdc.201100082 ↗
27. 10.1002/9781119640240.ch610.1002/9781119640240.ch6 ↗
28. 10.1007/s11356-015-4794-y10.1007/s11356-015-4794-y ↗
29. 10.1039/b706677p10.1039/b706677p ↗
30. 10.1016/j.molliq.2019.11216610.1016/j.molliq.2019.112166 ↗
31. 10.1002/tcr.20110003610.1002/tcr.201100036 ↗
32. 10.1002/advs.20200481910.1002/advs.202004819 ↗
33. 10.1039/D3CS00510K10.1039/D3CS00510K ↗
34. Zandu S. K. · Curr. Drug Metab. · 2020 · 12 · 26
35. 10.1007/s11581-021-04201-y10.1007/s11581-021-04201-y ↗
36. 10.1002/tcr.20230002610.1002/tcr.202300026 ↗
37. 10.1016/j.addr.2023.11515710.1016/j.addr.2023.115157 ↗
38. 10.1039/C9CS00016J10.1039/C9CS00016J ↗
39. 10.1016/j.scitotenv.2021.14730910.1016/j.scitotenv.2021.147309 ↗
40. 10.1016/j.ejpb.2015.04.03410.1016/j.ejpb.2015.04.034 ↗
41. 10.1021/mp500790t10.1021/mp500790t ↗
42. 10.1016/j.cocis.2007.10.00510.1016/j.cocis.2007.10.005 ↗
43. 10.1016/j.cocis.2016.05.01110.1016/j.cocis.2016.05.011 ↗
44. 10.3183/npprj-2015-30-01-p105-11110.3183/npprj-2015-30-01-p105-111 ↗
45. 10.1016/j.ijpharm.2020.11933510.1016/j.ijpharm.2020.119335 ↗
46. 10.1016/j.jconrel.2018.07.02910.1016/j.jconrel.2018.07.029 ↗
47. 10.1002/adfm.20200425710.1002/adfm.202004257 ↗
48. 10.1002/adma.20190110310.1002/adma.201901103 ↗
49. 10.1016/j.ijpharm.2016.11.02010.1016/j.ijpharm.2016.11.020 ↗
50. 10.3390/pharmaceutics1102009610.3390/pharmaceutics11020096 ↗
51. 10.3109/10837450.2015.113171810.3109/10837450.2015.1131718 ↗
52. 10.1016/S0169-409X(02)00113-810.1016/S0169-409X(02)00113-8 ↗
53. 10.1016/j.jconrel.2022.09.02510.1016/j.jconrel.2022.09.025 ↗
54. Qi Q. M. · J. Controlled Release · 2019 · 162 · 311
55. 10.1016/j.ijpharm.2021.12056010.1016/j.ijpharm.2021.120560 ↗
56. 10.1039/C6RA16926K10.1039/C6RA16926K ↗
57. 10.1021/acs.molpharmaceut.0c0059810.1021/acs.molpharmaceut.0c00598 ↗
58. 10.1080/03639045.2017.134978810.1080/03639045.2017.1349788 ↗
59. 10.1016/j.ijpharm.2022.12172410.1016/j.ijpharm.2022.121724 ↗
60. 10.1016/j.jconrel.2022.07.03510.1016/j.jconrel.2022.07.035 ↗
61. 10.1007/s11095-022-03238-610.1007/s11095-022-03238-6 ↗
62. 10.1016/j.ijpharm.2017.10.02410.1016/j.ijpharm.2017.10.024 ↗
63. 10.1248/cpb.41.143410.1248/cpb.41.1434 ↗
64. 10.1002/cmdc.20160048010.1002/cmdc.201600480 ↗
65. 10.1021/acs.chemrev.6b0056210.1021/acs.chemrev.6b00562 ↗
66. 10.1016/j.jconrel.2016.09.00310.1016/j.jconrel.2016.09.003 ↗
67. 10.1016/j.colcom.2019.10020410.1016/j.colcom.2019.100204 ↗
68. 10.1039/c2cs15362a10.1039/c2cs15362a ↗
69. 10.1016/j.ijpharm.2019.01.02110.1016/j.ijpharm.2019.01.021 ↗
70. 10.1021/acssuschemeng.0c0341910.1021/acssuschemeng.0c03419 ↗
71. 10.1021/acs.jpcb.9b0179910.1021/acs.jpcb.9b01799 ↗
72. 10.1002/adma.20190110310.1002/adma.201901103 ↗
73. 10.1021/acs.molpharmaceut.0c0059810.1021/acs.molpharmaceut.0c00598 ↗
74. 10.3390/pharmaceutics1406115210.3390/pharmaceutics14061152 ↗
75. 10.1080/1071754080200689810.1080/10717540802006898 ↗
76. 10.3390/pharmaceutics1412281810.3390/pharmaceutics14122818 ↗
77. 10.1038/s41598-019-56731-110.1038/s41598-019-56731-1 ↗
78. 10.1007/s13346-021-00951-410.1007/s13346-021-00951-4 ↗
79. 10.3390/pharmaceutics1606081710.3390/pharmaceutics16060817 ↗
80. 10.1016/j.ejpb.2007.12.00510.1016/j.ejpb.2007.12.005 ↗
81. 10.1021/acsbiomaterials.9b0024310.1021/acsbiomaterials.9b00243 ↗
82. 10.1007/s11095-022-03394-910.1007/s11095-022-03394-9 ↗
83. 10.1007/978-981-16-7152-4_1710.1007/978-981-16-7152-4_17 ↗
84. 10.1016/j.ijpharm.2011.10.03110.1016/j.ijpharm.2011.10.031 ↗
85. 10.1007/s11095-022-03322-x10.1007/s11095-022-03322-x ↗
86. 10.1080/17460441.2017.134421010.1080/17460441.2017.1344210 ↗
87. 10.1016/j.ijpharm.2013.08.01010.1016/j.ijpharm.2013.08.010 ↗
88. 10.1039/c2cp40122c10.1039/c2cp40122c ↗
89. 10.3390/pharmaceutics1604048010.3390/pharmaceutics16040480 ↗
90. 10.1016/j.ijpharm.2015.09.06610.1016/j.ijpharm.2015.09.066 ↗
91. 10.1021/acsami.2c1563610.1021/acsami.2c15636 ↗
92. Berton P. · 2021
93. 10.1002/adfm.20200425710.1002/adfm.202004257 ↗
94. 10.1007/s10924-020-01813-910.1007/s10924-020-01813-9 ↗
95. 10.1016/j.ijbiomac.2015.10.03110.1016/j.ijbiomac.2015.10.031 ↗
96. 10.1021/acsami.1c0311110.1021/acsami.1c03111 ↗
97. 10.2217/fmb-2019-029010.2217/fmb-2019-0290 ↗
98. 10.1016/j.ejps.2019.10504210.1016/j.ejps.2019.105042 ↗
99. 10.1208/s12249-021-01956-510.1208/s12249-021-01956-5 ↗
100. 10.1016/j.actbio.2020.08.02310.1016/j.actbio.2020.08.023 ↗